Respiratory Bronchiolitis-Interstitial Lung Disease in Chronic Kidney Disease Mimicking Uremic Lung: A Case Report
Downloads
Introduction: Uremic lung is a frequent complication of chronic kidney disease (CKD), while interstitial lung is an inflammation of the parenchyma which impairs its capacity. These two conditions manifest similar radiological features with bilateral diffuse infiltrates. Therefore, their clinical appearance and radiological lesions are often mistaken.
Case: This study reported a case of a 55-year-old male patient with shortness of breath for 1 month and worsening 1 week before hospitalization. The patient had a smoking history of 30 years with severe Brinkman index, hypertension (HT), and diabetes mellitus (DM). Auscultation examination showed crackles in both lungs, while laboratory results showed anemia, leukocytosis, increased urea and creatinine levels, and radiological features of bilateral infiltrate, suggesting a uremic lung. Furthermore, the ultrasonography showed bilateral chronic pyelonephritis and was diagnosed with CKD, uremic lung, pneumonia, anemia, hypoalbuminemia, mild hypokalemia, DM, and HT. The patient was treated with regular hemodialysis three times a week, and the serial chest X-ray showed persistent bilateral infiltrates after hemodialysis. An MSCT examination was also performed, and the results showed respiratory bronchiolitis-interstitial lung disease (RB-ILD). The patient was treated with antibiotic therapy, inhaled salbutamol, systemic steroids, and mucolytics. The patient was discharged from the hospital after the respiratory complaint improved.
Conclusion: Interstitial illness should be explored in uremia patients with bilateral infiltrates resembling uremic lungs and unresponsive to hemodialysis or other therapies. Risk factors for suspected interstitial lung disease should always be examined to improve patient management.
Yilmaz S, Yildirim Y, Yilmaz Z, et al. Pulmonary Function in Patients with End-Stage Renal Disease: Effects of Hemodialysis and Fluid Overload. Med Sci Monit 2016; 22: 2779–2784. [PubMed]
Sharma A, Sharma A, Gahlot S, et al. A Study of Pulmonary Function in End-Stage Renal Disease Patients on Hemodialysis: A Cross-Sectional Study. Sao Paulo Med J 2017; 135: 568–572. [PubMed]
Shaik L, Thotamgari SR, Kowtha P, et al. A Spectrum of Pulmonary Complications Occurring in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Cureus 2021; 13: 6–11. [PubMed] [CrossRef]
Al B, Gulati R. Uremic Alveoli : A Rare Case of Diffuse Alveolar Hemorrhage Due to Severe Uremia. iMedPub Journals 2018; 1–3. [WebPage]
Navaneethan SD, Mandayam S, Arrigain S, et al. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis 2016; 68: 414–421. [PubMed]
Mukai H, Ming P, Lindholm B, et al. Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease. Kidney Blood Press Res 2018; 43: 522–535. [PubMed] [CrossRef]
Khalid H, Fox C, Opole I. Uremic Lung: A Rare Entity in the Post Dialysis Era. Kansas J Med 2013; 6: 71–75. [CrossRef]
Lin S, Liao W, Huang S. Uraemic Lung in Severe Azotaemia. BMJ Case Rep 2013; 1: 1–2. [PubMed]
Himani N. Murdeshwar, Anjum F. Hemodialysis. Treasure Isl StatPearls Publ 2021; 1–3. [WebPage]
Kalchiem-Dekel O, Galvin JR, Burke AP, et al. Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History. J Clin Med; 7. Epub ahead of print 2018. [CrossRef]
Kreuter M, Herth FJF, Wacker M, et al. Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry - The EXCITING-ILD Registry. Biomed Res Int 2015; 2–4. [PubMed] [CrossRef]
Sieminska A, Kuziemski K. Respiratory Bronchiolitis-Interstitial Lung Disease. Orphanet J Rare Dis 2014; 9: 1–7. [PubMed] [CrossRef]
Remy-Jardin M, Campistron P, Amara A, et al. Usefulness of Coronal Reformations in the Diagnostic Evaluation of Infiltrative Lung Disease. J Comput Assist Tomogr 2003; 27: 266–273. [PubMed] [CrossRef]
Lioufas N, Hawley CM, Cameron JD, et al. Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review. Int J Hypertens; 2019. Epub ahead of print 2019. [PubMed] [CrossRef]
Webster AC, Nagler E V., Morton RL, et al. Chronic Kidney Disease. Lancet 2017; 389: 1238–1252. [CrossRef]
Cohen G. Immune Dysfunction in Uremia 2020. Toxins (Basel); 12. Epub ahead of print 2020. [CrossRef]
Vanholder R. "Uremic Toxin” Section in the Journal Toxins: A Powerful Tool to Bundle and Advance Knowledge on Uremia. Toxins (Basel) 2017; 9: 9–11. [CrossRef]
Lee SA, Cozzi M, Bush EL, et al. Distant Organ Dysfunction in Acute Kidney Injury: A Review. Am J Kidney Dis 2018; 72: 846–856. [CrossRef]
Anees M, Uz Zaman Adhami S, Aamer M, et al. Pulmonary Functions in Patients with End Stage Renal Disease and Their Effect after Hemodialysis. J Coll Physicians Surg Pakistan 2021; 31: 144–149. [CrossRef]
Kao CC, Yang WS, Fang JT, et al. Remote Organ Failure in Acute Kidney Injury. J Formos Med Assoc 2019; 118: 859–866. [PubMed] [CrossRef]
Teo BW, Chan GC, Leo CCH, et al. Hypertension and Chronic Kidney Disease in Asian Populations. J Clin Hypertens 2021; 23: 475–480. [CrossRef]
Nistala R, Savin V. Diabetes, Hypertension, and Chronic Kidney Disease Progression: Role of DPP4. Am J Physiol - Ren Physiol 2017; 312: F661–F670. [CrossRef]
Griffn KA. Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease. Hypertension 2017; 70: 687–694. [CrossRef]
Huan Y, Cohen DL, Townsend RR. Pathophysiology of Hypertension in Chronic Kidney Disease. Philadelphia: Elsevier Inc., 2015. Epub ahead of print 2015. [CrossRef]
Gutierrez A, Hernandez C, Mendoza-cabrera S, et al. Uremic Pneumonitis. G Ital Nefrol 2021; 1–2.
Wang PH, Lien WC. Point-of-Care Ultrasound in Management for Dyspneic Uremic Patients: a case report. BMC Nephrol 2019; 20: 1–4. [CrossRef]
Vadakedath S, Kandi V. Dialysis: A Review of the Mechanisms Underlying Complications in the Management of Chronic Renal Failure. Cureus; 9. Epub ahead of print 2017. [CrossRef]
Choi W Il, Dauti S, Kim HJ, et al. Risk Factors for Interstitial Lung Disease: A 9-Year Nationwide Population-Based Study. BMC Pulm Med 2018; 18: 1–7. [CrossRef]
Copyright (c) 2022 Budi Yanti, Mauliza Mauliza, Debby Sofiana, Aamir Shehzad
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.